• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Science

Science
Science RSS Feed RSS

Cancer research illustration

Cosegregation powerfully classifies BRCA 1/2 variants

Oct. 7, 2021
By John Fox
The French Cosegregation Variant study, a collaboration by cancer genetics clinics and laboratories led by geneticists at the Curie Institute in Paris, has demonstrated that cosegregation analysis represents a powerful tool for classifying variants in BRCA1 and BRCA2 breast-ovarian cancer predisposition genes.
Read More
Benjamin List and David W.C. MacMillan, Nobel Prize in Chemistry 2021

Sweet taste of success for asymmetric organocatalysis

Oct. 6, 2021
By Anette Breindl
The 2021 Nobel Prize in Chemistry was awarded today to Benjamin List, director of the Max Planck Institut for Carbon Research, and David MacMillan, professor of chemistry at Princeton University, "for their development of asymmetric organocatalysis."
Read More
Silhouette made of crumpled paper illustrating depression

Depression's doldrums linked to diagnostic duality at ECNP

Oct. 5, 2021
By Anette Breindl
"My fondest hope is that maybe depression and other mental health disorders may be diagnosed by underlying cause, rather than categorized dualistically," Edward Bullmore, director of the Wolfson Brain Imaging Centre, and head of the Department of Psychiatry at the University of Cambridge, told his audience at the European Congress of Neuropsychopharmacology (ECNP). "I think it's much more aligned with the way that the rest of medicine has been working for some time."
Read More
Nobel Prize winners in Physiology or Medicine
Fahrenheit 110

Nobel Prize for Red Hot Chili Pepper and Cool Mint receptors

Oct. 4, 2021
By Anette Breindl
The 2021 Nobel Prize in Physiology or Medicine was awarded Oct. 4 to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.”
Read More
Scientists in lab

IDH1 mutations affect antitumor immunity in glioma

Oct. 1, 2021
By Anette Breindl
Low-grade gliomas with mutated isocitrate dehydrogenase-1 (IDH1) produced and secreted higher levels of the cytokine granulocyte colony-stimulating factor (G-CSF) than other glioma types, which improved their antitumor immune response in animal models.
Read More
Cancer cells

Different way of looking allows new insights into cancer biology

Oct. 1, 2021
By Anette Breindl
By cataloging protein-protein interactions in cell lines, and combining their results with in vivo studies as well as publicly available data, scientists have defined new interactions that could be used diagnostically, and/or harnessed, for well-studied cancer drivers and more obscure proteins alike.
Read More
Bat
Anything but BANAL

Close SARS-CoV-2 relative strengthens natural origin theory

Sep. 28, 2021
By Anette Breindl
Horseshoe or Rhinopolus bats in Laos carry coronavirus species with a near-identical receptor binding domain to SARS-CoV-2, according to a paper posted on the preprint server Research Square by investigators from the Pasteur Institutes of Paris and Laos.
Read More
Red blood cell infected with malaria parasites

New proteasome inhibitors show antimalarial promise

Sep. 28, 2021
By John Fox
An international collaborative study has identified several novel derivatives of anticancer proteasome inhibitors (PIs) that had potential as antimalarials, the authors reported in the September 28, 2021, online edition of Proceedings of the National Academy of Sciences.
Read More
3D illustration of headache

Infection derails healing after brain injury

Sep. 27, 2021
By Anette Breindl
Researchers at the National Institutes of Neurological Disorders and Stroke have demonstrated that systemic infections after either traumatic brain injury or cerebrovascular injury impair the repair of blood vessels by competing for the services of immune cells, in particular, proangiogenic myeloid cells.
Read More
Science-James-Naismith-9-22

Inhaled antibodies brought to SARS-CoV fight

Sep. 23, 2021
By Anette Breindl
Trimers of nanobodies, a simpler form of antibody made by some animal species, were effective at preventing and treating COVID-19 in preclinical studies, researchers reported in the Sept. 22, 2021, issue of Nature Communications. The findings, along with others, could form the basis of an inhaled biologics treatment for COVID-19 and, ultimately, other respiratory diseases.
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 … 176 177 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe